Mckinley Capital Management LLC Regenxbio Inc. Transaction History

Mckinley Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$42.0 - $59.29 $37,296 - $52,649	-888 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$40.82 - $62.45 $12,368 - $18,922	303 Added 51.79%	888 $51,000
Q4 2018 Feb 11, 2019	SELL	$39.11 - $75.15 $25,421 - $48,847	-650 Reduced 52.63%	585 $25,000
Q3 2018 Nov 08, 2018	SELL	$65.0 - $82.15 $7,280 - $9,200	-112 Reduced 8.31%	1,235 $94,000
Q2 2018 Jul 13, 2018	SELL	$27.2 - $74.35 $2,856 - $7,806	-105 Reduced 7.23%	1,347 $96,000

Q1 2018 May 04, 2018	SELL	$24.05 - $37.5 $968,469 - $1.51 Million	-40,269 Reduced 96.52%	1,452 $43,000
Q4 2017 Feb 08, 2018	BUY	$26.0 - $34.6 $754 - $1,003	29 Added 0.07%	41,721 $1.39 Million
Q3 2017 Nov 13, 2017	BUY	$18.0 - $32.95 $750,456 - $1.37 Million	41,692	41,692 $1.37 Million

193

42.1M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $471M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mckinley Capital Management LLC with notifications on news.